News | Imaging Software Development | February 15, 2022

Fivos Health Spins Off Cardiovascular Imaging Business into Astute Imaging

New focus will leverage the power of cloud-based AI technologies combined with team expertise to advance imaging services and treatment planning.


February 15, 2022 - Fivos Inc., formerly known as Medstreaming/M2S, a leading company providing comprehensive data solutions for specialty providers, medical registries and device manufacturers, announced the spin-off of its imaging services business into Astute Imaging. The new company will focus on adopting state-of-the-art artificial intelligence (AI) and cloud technologies to advance its unique patented imaging software and enable precision medicine for healthcare providers and device companies.

Jay Colfer, CEO of Fivos, said, “Today’s announcement marks an important step forward for Fivos and will allow us to our focus on our core lines of business – vascular and cardiovascular workflow solutions for providers and quality data insights for registries and industry that advance patient care and device innovation.”

Astute Imaging provides Software as a Service (SaaS) products to physicians with 24/7 access for pre- and post-surgery planning and follow-up tools including 3D modeling, reconstruction, measurements, analysis, tracking, and alerts management. The company also offers core-lab imaging service for device manufacturers with nearly two decades of experience providing high-quality, cost-effective image management, allowing them to streamline their clinical trials.

“We are excited to be solely focused on the imaging services business, where our core knowledge and expertise lies and where our vision is to apply data-driven enhancements and automation for procedure planning and follow-up, to enable effective and optimized patient-centric care management for healthcare providers and device manufacturers,” Wael Elseaidy, CEO of Astute Imaging, stated. “Our top priority is to maintain business continuity for our customers and employees. Astute Imaging will be a bridge to the next level of imaging services where it becomes faster, smarter, and available anytime, anywhere.”

Astute Imaging will be led by Elseaidy and Ewald de Vries, former founders of Medstreaming (currently known as Fivos). Both founders have more than 25 years of experience in the healthcare IT industry, particularly in the area of cardiovascular imaging. In 2016, Medstreaming acquired M2S with its revolutionary cardiovascular imaging solutions such as the Treatment Planning software (Preview) and the Patient Evaluation and Management System (PEMS).

“Our focus will be to leverage the power of cloud-based AI technologies combined with our team expertise to advance imaging services and treatment planning,” de Vries, Astute imaging CTO, indicated. “Currently, Astute has access to ­more than 345,000 imaging records and a multidisciplinary team of technology and medical experts. We look forward to provide ongoing support to our customers with these resources and expertise.”


Related Content

News | Artificial Intelligence

April 24, 2024 — Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-powered medical ...

Home April 24, 2024
Home
News | Artificial Intelligence

April 23, 2024 — A recent study designed and implemented by investigators at Cedars-Sinai found that artificial ...

Home April 23, 2024
Home
News | Artificial Intelligence

April 18, 2024 — Karoo Health, the only operational provider of cardiac value-based care (VBC) enablement with published ...

Home April 18, 2024
Home
News | Artificial Intelligence

April 6, 2024 — Experts from the Smidt Heart Institute at Cedars-Sinai will share new research and participate in more ...

Home April 06, 2024
Home
News | Artificial Intelligence

March 28, 2024 — Cleerly, the company on a mission to create a new standard of care to aid in the diagnosis of heart ...

Home March 28, 2024
Home
News | Artificial Intelligence

March 27 2024 — HeartFlow, Inc., a leader in AI-driven healthcare technology, announced the launch of the DECIDE ...

Home March 27, 2024
Home
News | Artificial Intelligence

March 7, 2024 — GE HealthCare will showcase its industry-leading portfolio of artificial intelligence (AI)-enabled ...

Home March 07, 2024
Home
News | Artificial Intelligence

March 1, 2024 — Two new studies by Cedars-Sinai investigators support using artificial intelligence (AI) to predict ...

Home March 01, 2024
Home
News | Artificial Intelligence

February 28, 2024 — Artificial intelligence (AI) may transform cardiovascular medicine. For now, though, many challenges ...

Home February 28, 2024
Home
Subscribe Now